AHCYL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.396580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.096800E-01
Normal-vs-Stage2
1.170430E-01
Normal-vs-Stage3
2.460000E-01
Normal-vs-Stage4
8.057400E-01
Stage1-vs-Stage2
3.600800E-01
Stage1-vs-Stage3
1.988300E-02
Stage1-vs-Stage4
5.085200E-01
Stage2-vs-Stage3
1.332240E-01
Stage2-vs-Stage4
1.736030E-01
Stage3-vs-Stage4
8.002600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.288190E-01
Normal-vs-AfricanAmerican
8.144200E-01
Normal-vs-Asian
1.970990E-01
Caucasian-vs-AfricanAmerican
1.202780E-01
Caucasian-vs-Asian
6.984400E-01
AfricanAmerican-vs-Asian
1.857420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.346160E-01
Normal-vs-Female
1.728620E-01
Male-vs-Female
3.152800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.787400E-01
Normal-vs-Age(41-60Yrs)
3.157800E-01
Normal-vs-Age(61-80Yrs)
1.100430E-01
Normal-vs-Age(81-100Yrs)
9.776300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.217800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.733800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.038800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.931670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.077900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.482800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.171500E-02
Normal-vs-Daily Drinker
3.076600E-01
Normal-vs-Weekly Drinker
1.245810E-01
Normal-vs-Occasional Drinker
2.706800E-01
Normal-vs-Social Drinker
4.468400E-01
Non Drinker-vs-Daily Drinker
3.877600E-01
Non Drinker-vs-Weekly Drinker
9.392400E-01
Non Drinker-vs-Occasional Drinker
1.290840E-01
Non Drinker-vs-Social Drinker
7.099700E-02
Daily Drinker-vs-Weekly Drinker
4.450200E-01
Daily Drinker-vs-Occasional Drinker
2.881600E-02
Daily Drinker-vs-Social Drinker
1.883730E-02
Weekly Drinker-vs-Occasional Drinker
2.580800E-01
Weekly Drinker-vs-Social Drinker
1.770970E-01
Occasional Drinker-vs-Social Drinker
6.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.906980E-01
Normal-vs-Grade 2
5.498100E-02
Normal-vs-Grade 3
6.226300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.519000E-01
Grade 1-vs-Grade 3
9.326000E-01
Grade 1-vs-Grade 4
1.906980E-01
Grade 2-vs-Grade 3
3.996600E-01
Grade 2-vs-Grade 4
5.498100E-02
Grade 3-vs-Grade 4
6.226300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.637500E-02
Normal-vs-NonDiabetic
8.756300E-02
Diabetic-vs-NonDiabetic
4.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.163200E-01
Normal-vs-NoPancreatitis
8.262400E-02
Pancreatitis-vs-NoPancreatitis
7.641800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.303800E-01
Normal-vs-N1
1.222160E-01
N0-vs-N1
9.745200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.707400E-01
Normal-vs-TP53-NonMutant
4.263000E-01
TP53-Mutant-vs-TP53-NonMutant
3.129200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
